7N91 image
Deposition Date 2021-06-16
Release Date 2022-07-06
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7N91
Title:
P70 S6K1 IN COMPLEX WITH MSC2317067A-1
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.27
R-Value Work:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Ribosomal protein S6 kinase beta-1
Gene (Uniprot):RPS6KB1
Mutations:T412E
Chain IDs:A, B
Chain Length:340
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers.
J.Med.Chem. 64 14603 14619 (2021)
PMID: 34596404 DOI: 10.1021/acs.jmedchem.1c01087

Abstact

Herein, we report the discovery of a novel class of quinazoline carboxamides as dual p70S6k/Akt inhibitors for the treatment of tumors driven by alterations to the PI3K/Akt/mTOR (PAM) pathway. Through the screening of in-house proprietary kinase library, 4-benzylamino-quinazoline-8-carboxylic acid amide 1 stood out, with sub-micromolar p70S6k biochemical activity, as the starting point for a structurally enabled p70S6K/Akt dual inhibitor program that led to the discovery of M2698, a dual p70S6k/Akt inhibitor. M2698 is kinase selective, possesses favorable physical, chemical, and DMPK profiles, is orally available and well tolerated, and displayed tumor control in multiple in vivo studies of PAM pathway-driven tumors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures